- CEO
- Petr Kasa
- Full Time Employees
- 103
- Sector
- Retail trade
- Industry
- Drugstore chains
- Address
- CeskomoravskA 2408/1 Prague ON Czech Republic 190 00
- IPO Date
- Oct 26, 2020
- Business
- Pilulka Lékárny a.s. (PINK.PR) operates as a technology-driven pharmacy group focused on the retail and online distribution of medicinal products, pharmacy goods, cosmetics, dietary supplements, healthy lifestyle items, and related services under the Pilulka brand; it runs brick-and-mortar pharmacies including its own and partner locations, alongside a leading e-commerce platform with portals such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and Pilulka.at offering features like Pilulka Express rapid delivery, dispensing boxes, e-health tools including the Plus Care mobile app, blood and DNA testing subscriptions via Pilulka PRO membership, and Korean Beauty Store selections; the company serves consumer markets in the Czech Republic, Slovakia, Romania, Hungary, and Austria through owned distribution warehouses, franchise networks, and digital services connecting pharmaceutical producers, distributors, health insurers, and healthcare providers. Founded in 2013 and headquartered at Českomoravská 2408/1, Prague 9, Czech Republic, Pilulka Lékárny a.s. acts as the parent of the Pilulka Group encompassing subsidiaries across these regions and listed its shares on the Prague Stock Exchange's START market in October 2020. In recent developments, the company underwent major transformation in 2024 including staff and supplier reductions, halving marketing costs, cutting logistics expenses by 30 percent, and settling most overdue supplier invoices, resulting in turnover declining 36 percent to CZK 1.35 billion amid a 40 percent drop in e-shop orders; it was acquired last year by Tomas Cupr, founder of Rohlik.cz, through his Growth Expert vehicle, with new leadership from Billy and Alza executives appointed in April 2025, and management now plans conservative sales growth targeting EBITDA and cash flow profitability.